Cytokinetics CYTK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration Revenues | $2.64M-4.3% | $2.76M+42.3% | $1.94M-19.9% | $2.42M+53.0% | $1.58M-18.1% | |
| License And Milestone Revenues | $11.93M-20.5% | $15M— | $0-100% | $64.35M— | $0-100% | |
| Net Product Revenue | $4.79M— | —— | —— | —— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytokinetics break its business down?
- Cytokinetics (CYTK) reports revenue by product across 3 parts — Collaboration Revenues, License And Milestone Revenues and Net Product Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytokinetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytokinetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
